Company Website

Contact Information:

Bill Brum, Jr.
wbrumjr@dsi.com
904-537-5051

Virtual Exhibit Hall Home

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy.

Additional Information:
Breast-Important Safety Information
Breast-Prescribing Information
Gastric-Important Safety Information